Masimo stock: buy or sell?

MASI stock price: $147.87 -0.09% At close on October 18th, 2019

Updated on:
October 18th, 2019

0

Shares of Masimo ended on October/18 at $147.87 and remained steady a neutral -0.09%.

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide.

Should I buy Masimo stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Masimo stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Masimo stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we collected 10 ratings published for MASI stock in the last 30 days.

The general sentiment of these ratings is bullish for MASI stock, with 8 positive ratings.
Is MASI a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-1UBS Groupn/aBuy
2019-8-1Stifel Nicolausn/aBuy
2019-8-1BTIG Researchn/aHold
2019-5-7UBS GroupBuyBuy
2019-5-7Piper Jaffray Companiesn/aOverweight
2019-5-17Piper Jaffray Companiesn/an/a
2019-4-9Needham & Company LLCn/aBuy
2019-3-13Needham & Company LLCn/aBuy
2019-2-27Piper Jaffray Companiesn/aOverweight
2019-2-1Needham & Company LLCn/aBuy

Masimo stock analysis

Daily outlook

Masimo closed on October/18 at $147.87 and remained stable a neutral -0.09%.

Shares of Masimo closed on October 18th at $147.87 and remained constant a neutral -0.09%. On July, MASI hit new all time highs, pushing higher previous ATH of $160.13 recorded on July. New ATHs are usual entry points for many trading setups as there aren't higher resistences.

MASI stock chart (daily)

Weekly outlook

Masimo shares gained 1.69% this week, ending at $147.87.

MASI marked an uptrend of rising tops and rising bottoms. Since its last top late July at $160.25, price slid and bounced up back from $139.36. Breaking down under $139.36 would cancel the current uptrend and it might test lower supports. Note that $160.25 might act as a resistance line. Not so far away is the last all-time high Masimo marked late July. Early January MASI price bounced up over the SMA of 40 weeks that acted as support stopping new slides. By mid February, SMA10w and SMA20w crossed up triggering a rise of 16.17%.

MASI stock chart (weekly)

Masimo stock price history

Masimo stock went public on August 8th, 2007 with a price of $16.471. Since then, MASI stock surged a 797.80%, with an average of 66.50% per year. If you had invested right after MASI's IPO a $1,000 in Masimo stock in 2007, it would worth $7,978.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Masimo stock historical price chart

MASI stock reached all-time highs on July with a price of $160.25.

Masimo stock price target is $156.50

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' MASI stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 8 price predictions for Masimo stock:
MASI stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-1UBS GroupRaises Target$172.00$180.004.7%
2019-8-1Stifel NicolausRaises Target$165.00$170.003%
2019-5-7UBS GroupRaises Target$147.00$160.008.8%
2019-5-7Piper Jaffray CompaniesReiterates$140.00$148.005.7%
2019-5-17Piper Jaffray CompaniesRaises Target$148.00$160.008.1%
2019-3-13Needham & Company LLCRaises Target$148.00$155.004.7%
2019-2-27Piper Jaffray CompaniesReiteratesn/a$140.00-
2019-2-1Needham & Company LLCReiteratesn/a$139.00-
(in average)$153.30$156.502.0%
The price target for Masimo stock is $156.50, moving in a range between $180.00 and $139.00.

Financials and fundamental analysis

Earnings date and Earnings per Share

Masimo reported more than good results for 2018-Q4 on February. Masimo rose Earnings per Share (EPS) by 15.30%, beating analysts consensus of $0.72. Masimo posted $0.83.
MASI earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a0.82n/a
2017-Q2-n/a0.83n/a
2017-Q32017-10-310.530.732.1%
2017-Q42018-02-270.610.7218.0%
2018-Q12018-05-020.70.757.1%
2018-Q22018-08-010.720.731.4%
2018-Q32018-10-310.680.714.4%
2018-Q42019-02-260.720.8315.3%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Masimo annual turnover jumped a pretty good 8.61% to $858.29 million dollars from $790.25 marked in 2017. When comparing 2018 vs 2017, in contrary, profit margin (that is, the net income divided by revenues) rose a 6.76% to 22.55%.

MASI annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$547 M-$58 M10.7%-
2014$587 M7.20%$73 M12.4%24.22%
2015$630 M7.41%$83 M13.2%14.87%
2016$695 M10.24%$301 M43.3%260.94%
2017$790 M13.77%$125 M15.8%-58.50%
2018$858 M8.61%$194 M22.5%55.10%

Quarterly financial results

Masimo posted $223.13 million in revenues for 2018-Q4, a 5.96% up compared to previous quarter. Reported quarter income marked $46.93 million with a profit margin of 21.03%. Profit margin slipped a -6.09% compared to previous quarter when profit margin was 27.13%. When comparing revenues to same quarter last year, Masimo sales marked a beatiful gain and appreciated a 3.40%.
MASI quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$186 M-$45 M24.3%-
2017-Q2$193 M3.56%$47 M24.2%2.98%
2017-Q3$194 M0.39%$39 M20.3%-15.95%
2017-Q4$216 M11.41%$-1 M-0.4%-102.31%
2018-Q1$213 M-1.32%$46 M21.4%-5,125.33%
2018-Q2$212 M-0.63%$44 M20.7%-3.89%
2018-Q3$211 M-0.49%$57 M27.1%30.27%
2018-Q4$223 M5.96%$47 M21.0%-17.84%

Masimo ownership

When you are planning to buy a stock, it's always worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Masimo, 8.80% of all outstanding shares are owned by its staff.

Bearish positions for MASI stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Masimo:

MASICAHCNMDGEOMI
Market cap$7.9 B$15.1 B$2.8 B$78.2 B$449.5 M
Total shares53.3 M292.4 M28.3 M8,730.0 M63.0 M
Float shares49.2 M297.7 M27.6 M8,710.0 M60.5 M
  - Institutional holdings (%)84.4%92.4%97.5%58.6%98.2%
  - Insider holdings (%)8.8%0.3%1.8%0.2%3.5%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

Masimo summary

Friday, October 18th, 2019
Open$147.58
Close$147.87
Day range$146.50 - $148.69
Previous close$148.00
Session gain-0.09%
Average true range$3.21
50d mov avg$149.59
100d mov avg$148.65
200d mov avg$139.29
Daily patternlt02a
Weekly pattern lb03a

Masimo performance

To measure stock performance is always good to benchmark with competitors or related stocks. We selected Cardinal Health, CONMED, General Electric, Owens & Minor, Koninklijke Philips, ResMed, Thermo Fisher Scientific and Universal Forest Products as the bechmarking frame for Masimo stock.
Stock3m6m12m
MASIMasimo-3.60%20.74%27.51%
CAHCardinal Health15.72%14.38%0.98%
CNMDCONMED16.00%23.41%37.36%
GEGeneral Electric-10.67%-3.97%-25.46%
OMIOwens & Minor170.45%111.87%-51.72%
PHGKoninklijke Phili...0.05%12.05%11.50%
RMDResMed6.59%33.06%29.16%
TMOThermo Fisher Sci...-2.84%8.47%24.23%
UFPIUniversal Forest ...15.12%32.32%44.78%

Masimo competitors

We selected a few stocks to conform a list of Masimo competitors to review if you are interested in investing in MASI: